Abstract
Transcatheter aortic valve implantation (TAVI) is a recognized therapy for patients with symptomatic severe aortic stenosis (AS). TAVI is superior compared to medical therapy as for mortality in extreme-risk patients, is non-inferior or superior to surgery in high-risk patients and non-inferior to surgery in intermediate-risk patients. However, several limitations affect outcomes after TAVI. Adverse events related to this procedure, like vascular complications, need for pacemaker implantation, paravalvular regurgitation, can be factors limiting TAVI treatment in younger patients at lower risk, as well as uncertainties regarding valve durability. This review tries to figure out some of the main complications still unsolved after TAVI.
MeSH terms
-
Aortic Valve / diagnostic imaging
-
Aortic Valve / physiopathology
-
Aortic Valve / surgery*
-
Aortic Valve Insufficiency / etiology
-
Aortic Valve Insufficiency / therapy
-
Aortic Valve Stenosis / diagnostic imaging
-
Aortic Valve Stenosis / physiopathology
-
Aortic Valve Stenosis / surgery*
-
Arrhythmias, Cardiac / etiology
-
Arrhythmias, Cardiac / therapy
-
Cardiac Pacing, Artificial
-
Fibrinolytic Agents / therapeutic use
-
Heart Valve Prosthesis
-
Humans
-
Pacemaker, Artificial
-
Postoperative Complications / diagnosis
-
Postoperative Complications / etiology*
-
Postoperative Complications / therapy
-
Prosthesis Design
-
Prosthesis Failure
-
Risk Factors
-
Severity of Illness Index
-
Stroke / etiology
-
Stroke / therapy
-
Thrombosis / etiology
-
Thrombosis / therapy
-
Transcatheter Aortic Valve Replacement / adverse effects*
-
Transcatheter Aortic Valve Replacement / instrumentation
-
Treatment Outcome
-
Vascular Diseases / etiology
-
Vascular Diseases / therapy